Cellectar Biosciences, Inc. (CLRB)
3.04
+0.22
(+7.80%)
USD |
NASDAQ |
Feb 06, 16:00
3.06
+0.02
(+0.66%)
After-Hours: 20:00
Cellectar Biosciences Research and Development Expense (TTM) : 14.55M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Imunon, Inc. | 7.524M |
| PDS Biotechnology Corp. | 19.15M |
| PAVmed, Inc. | 3.472M |
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| Alnylam Pharmaceuticals, Inc. | 1.248B |